Pre-clinical-stage pharmaceutical company, MIRA Pharmaceuticals (MIRA) prices an initial public offering of 1,275,000 shares at an initial public offering price of $7.00 per share.
Aggregate gross proceeds of $8.9M.
Underwriters have a 45-day option to purchase up to 191,250 additional shares.
The offering is expected to close on August 7, 2023.
Net proceeds from the offering to advance its clinical development programs and for working capital and general corporate purposes.
#MIRA #Pharmaceuticals #prices #equity #offering #PendingMIRA
